NEW: The DOJ is further relaxing rules governing political activities for presidential appointees like AG Blanche, as he makes appearances at political events and alongside candidates www.pbs.org/newshour/pol...
A man with a gene mutation expected to give him Alzheimer's 25 years ago has somehow escaped that fate. Scientists are exploring why, hoping the answers could help many other people. @aliroginpbs.bsky.social and I discussed this fascinating case on @pbsnews.org www.pbs.org/newshour/sho...
PBS Newshour: 'What to know about RFK Jr.’s efforts to address long COVID research and treatments'
Features Dr. Michael Peluso of UCSF & Meighan Stone from Long COVID Campaign
My latest Substack on my experience on SSRIs before, during and after pregnancy: alirogin.substack.com/p/notes-from...
📺 I joined @aliroginpbs.bsky.social on @pbsnews.org last night to talk about Project Esther and how it relates to the Trump administration's approach to antisemitism
My interview out today with @pbs.org on extending our healthspan www.pbs.org/newshour/sho... @aliroginpbs.bsky.social
Casey Means is President Trump’s pick for Surgeon General. A hero of the MAHA movement, Means is also a close ally of Robert Kennedy Jr. And she has strong opinions on the American healthcare system.
Our story @pbsnews.org @aliroginpbs.bsky.social
Hi friends - I am starting a Substack where I'll be sharing updates and musings on my journey through the Fertility Industrial Complex, my genetic risk of cancer and motherhood. Please subscribe and share if you're interested! alirogin.substack.com?r=dz3un&utm_...
NEW @pbsnews.org Daily News Lesson: Artists with disabilities let their creativity soar at this Utah studio
Ask students: Why did Bingham decide to start Jump the Moon?
NEW PBS @pbsnews.org Classroom Daily News Lesson: How synthetic braiding hair may be putting Black women’s health in jeopardy
Ask students: What is needed to understand the long-term effects of synthetic braids?
#healthED #sschat @actecareertech.bsky.social @aliroginpbs.bsky.social
Medical breakthroughs that might offer hope to patients with rare neurological diseases are often the purview of academic researchers working at universities. But a directive from the NIH under the Trump administration aimed to reduce funding for many of the studies' essential costs. buff.ly/Hlc1uFH
